1. Waller SJ, Ratty A, Burbach JPH, Murphy D 1998. Transgenic and transcriptional studies on neurosecretory cell gene expression. Cellular & Molecular Neurobiology 18, 149-171.

2. Iwasaki Y, Oiso Y, Saito H, Majzoub JA 1997. Positive and negative regulation of the rat vasopressin gene promoter. Endocrinology 138, 5266-5274.

3. Russell JA, Leng G 1998. Sex, parturition and motherhood without oxytocin? Journal of Endocrinology 157, 343-359.

4. Bichet DG, Arthus M-F, Barjon JN, et al. 1987. Human platelet fraction arginine-vasopressin: Potential physiological role. Journal of Clinical Investigation 79, 881-887.

5. Laycock JF, Hanoune J 1998. From vasopressin receptor to water channel: intracellular traffic, constraint and by-pass. Journal of Endocrinology 159, 361-372.

6. Marples D (2000). Water channels: who needs them anyway? Lancet 355: 1571-1572.

7. King LS, Choi M, Fernandez PC, Cartron JP, Agre P 2001. Defective urinary-concentrating ability due to a complete deficiency of aquaporin-1. New England Journal of Medicine. 345: 175-179.

8. Yasui M, Zelenin SM, Celsi G, Aperia A 1997. Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. American Journal of Physiology- Renal Fluid & Electrolyte Physiology 272, F443-F450.

9. Agre P, Brown D, Nielsen S 1995. Aquaporin water channels: unanswered questions and unresolved controversies. Current Opinion in Cell Biology 7, 472-483.

10. Hurbin A, Boisin-Agasse L, Orcel H, Rabie A et al. 1998. The V(1a) and V(1b), but not the V2, vasopressin receptor genes are expressed in the supraoptic nucleus of the rat hypothalamus, and the transcripts are essentially colocalized in the vasopressinergic magnocellular neurons. Endocrinology 139, 4701-4707.

11. Ludwig M 1998. Dendritic release of Vasopressin and Oxytocin. Journal of Neuroendocrinology 10, 881-895.

12. McKenna K, Thompson C 1998. Osmoregulation in clinical disorders of thirst and thirst appreciation. Clinical Endocrinology 49, 139-152.

13. Zimmerman EA, Ma L-Y, Nilaver G 1987. Anatomical basis of thirst and vasopressin secretion. Kidney International 32, suppl 21, 514-519.

14. Nishimori K, Young LJ, Guo Q, Wang Z et al. 1996. Oxytocin is required for nursing but is not essential for parturition or reproductive behaviour. Proceedings of the National Academy of Sciences of the USA 93, 11699-11704.

15. Goodwin TM, Valenzuela GJ, Silver H, Creasy G 1996. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. Obstetrics and Gynecology 88, 331-336.

16. Seckl JR, Dunger DB, Bevan JS, Nakasu Y, Chowdrey C, Burke CW, Lightman SL 1990. Vasopressin antagonist in early postoperative diabetes insipidus. Lancet 355, 1353-1356.

17. Baylis PH, Cheetham T 1998. Diabetes Insipidus. Archives of Disease in Childhood 79, 84-89.

18. Polymeropoulos MH, Swift RF, Swift M 1994. Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4. Nature Genetics 8, 95-97.

19. Hofman S, Bezold R, Jaksch M, Kaufold P, Obermaier-Kusser B, Gerbitz K-D 1997. Analysis of the mitochondrial DNA from patients with Wolfram (DIDMOAD) syndrome. Molecular and Cellular Biochemistry 174, 209-213.

20. Nijenhuis M, van den Akker, ELT, Zalm R et al. 2001. Familial neurohypophyseal diabetes insipidus in a large dutch kindred: effect of the onset of diabetes on growth in children and cell biological defects of the mutant vasopressin prohormone. Journal of Clinical Endocrinology and Metabolism 86: 3410-3420.

21. Ito M, Jameson JL, Ito M 1997. Molecular basis of autosomal dominant Neurohypophyseal Diabetes Insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. Journal of Clinical Investigation 99,2897-1905.

22. Siggaard C, Ritig S, Corydon TJ et al. 1999. Clinical and molecular evidence of the abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation. Journal of Clinical Endocrinology and Metabolism 84: 2933-2941.

23. Baylis PH 1995. Vasopressin and its Neurophysin. In Endocrinology 3rd edition, Degroot LJ (Ed), Philadelphia USA, WB Saunders.

24. Diederich S, Eckmanns T, Exner P et al. 2001. Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults. Clinical Endocrinology 54: 665-671.

25. Kurokowa H, Fujisawa I, Nakano Y, Akagi H, Ikeda K, Uokawa K, Tanaka Y 1998. Posterior lobe of the pituitary gland; correlation between signal intensity on T1-weighted images and vasopressin concentration. Radiology 207, 79-83.

26. Barbieris C, Mouillac B, Durroux T 1998. Structural basis of vasopressin/oxytocin receptor function. Journal of Endocrinology 156, 223-229.

27. Mulders SM, Bichet DG, Rijss JPL, Kamsteeg E-J, Arthus M-F, Lonergan M, Fujiwara M, Morgan K, Leijendekker R, van der Sluijs P, van Os CH, Deen PMT 1998. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the golgi complex. Journal of Clinical Investigation 102, 57-66.

28. Adrogue HJ and Madias NE. Hyponatraemia. New England Journal of Medicine 2000; 342: 1581-1589.

29. Verbalis JG 1989. Hyponatremia. In Baylis PH (ed): Water and Salt Homeostasis in Health and Disease. London, Baillière Tindall, pp 499-530.

30. Ball SG, Baylis PH 1998. Mechanisms of drug induced hyponatraemia . Adverse Drug Reaction Bulletin 192, 734-737.

31. Ishikawa S-E, Saito T, Fugagawa A et al. 2001. Close association of urnary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatraemia in elderly subjects. Journal of Clinical Endocrinology and Metabolism 86: 1665-1671.

32. Saito T, Ishikawa S, Abe K et al. 1997. Acute aquaresis by the non-peptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone. Journal of Clinical Endocrinology and Metabolism 82, 1054-1057.

27. Ball SG, Vaidja B, Baylis PH 1997. Hypothalamic adipsic syndrome: diagnosis and management. Clinical Endocrinology 47, 405-409.